drugset / Trial / NCT02068092

Olive Oil for High Risk Breast Cancer Prevention in Women

NCT02068092

Phase 2/3 Completed 51 enrolled The Methodist Hospital Research Institute
NaSingle-groupOpen-labelPrevention

Summary

This is a pilot study evaluating the effect of hydroxytyrosol, a component of olive oil, on mammographic density in women at high risk of developing breast cancer.

Timeline

Start
2013-12
Primary completion
2021-07
Completion
2021-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxytyrosol Small molecule 25 mg Oral

Indications